Ventripoint Diagnostics will exhibit its AI-driven cardiac imaging technology, VMS+™, at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology in Italy. The event gathers over 1,000 specialists focused on congenital heart disease (CHD), highlighting Ventripoint's role in advancing echocardiography for lifelong CHD patient care. VMS+™ offers MRI-level accuracy in cardiac volume measurement, streamlining clinical workflows and supporting better patient management. Ventripoint aims to integrate VMS+™ more widely into routine practice throughout 2026.
Okeanis Eco Tankers Corp. declared a $2.00 per share dividend for Q1 2026. The company's shares will trade ex-dividend starting May 27 on the Oslo Stock Exchange and May 28 on the New York Stock Exchange. This dividend reflects the company's ongoing ...
Aduro Clean Technologies, a clean tech company specializing in chemical recycling of low-value raw materials, has received final approval to list its common shares on the Toronto Stock Exchange (TSX) under the symbol ACT starting May 27, 2026. Concur...
Aduro Clean Technologies Inc., a cleantech company specializing in converting low-quality materials into valuable resources, has received final approval to list its common shares on the Toronto Stock Exchange (TSX) under the ticker "ACT" starting May...
The 2026 China (Jinhua Mountain) International Camping Congress was held from May 16-17 in Zhejiang Province, focusing on integrating culture, sports, tourism, and industry to develop camping tourism and leisure. The event attracted around 200 guests...
The Schall Law Firm is investigating UP Fintech Holding Limited for possible securities law violations after a Reuters report revealed China's crackdown on illegal cross-border securities trading. The report accused UP Fintech's Tiger subsidiary of o...
